and electron microscopy. There was a diffuse, acute interstitial nephritis comprising mainly plasma cells with scattered lymphocytes, but no eosinophils (Figure 1). More than 90% of the tubules ...

Background: Discoid Lupus Erythematosus (DLE ... with a narrow size distribution by transmission electron microscopy TEM analysis. Ratio 16:1 and 5:1 of miRNAi:liposome has been evaluated using ...

We investigated its role in kidney inflammation and fibrosis in a murine model of lupus nephritis (LN), and the clinico-pathological ... for each specimen using a Zeiss™ Axioscope 5 upright microscope ...

Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

REPEAT kidney biopsies may play an essential role in managing lupus nephritis, particularly for patients whose disease ...

Panelists discuss the challenges patients face in accessing lupus nephritis treatment and the resources available to support ...

Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response. Long-term follow-up data offer valuable ...

“We are thrilled to achieve this milestone that will provide access to LUPKYNIS in Japan, where there is a high rate of lupus nephritis among Japanese lupus patients. Our successful strategic ...

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN). Gazyva is an engineered humanized monoclonal antibody ...

Roche announced positive topline results from the phase III REGENCY study of Gazyva/Gazyvaro (obinutuzumab) in people with active lupus nephritis. In the study, a higher proportion of people treated ...

After collecting a handful of oncology approvals since its first leukemia nod in 2013, Roche’s Biogen-partnered Rituxan successor, Gazyva, is chasing new horizons in active lupus nephritis.